Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bin Gao, MD，PhD
Tang-Du Hospital
Principal Investigator - Hui Liu, MD，PhD
Luoyang Central Hospital
Principal Investigator - HuiMin Zhou, MD，PhD
First Hospital of Hebei Medical University
Principal Investigator - Huige Shao, MD，PhD
Changsha Central Hospital
Principal Investigator - Jianhua Ma, MD，PhD
The First Affiliated Hospital with Nanjing Medical University
Principal Investigator - Jing Yang, MD，PhD
The First Affiliated Hospital of Shanxi Medical University
Principal Investigator - Jingna Lin, MD，PhD
Tianjin People's Hospital
Principal Investigator - Lan Xu, MD，PhD
WuXi Central Hospital
Principal Investigator - Lin Liao, MD，PhD
Qianfoshan Hospital
Principal Investigator - Linong Ji, MD，PhD
Beijing University People's Hospital
Principal Investigator - MingHui Hou, MD，PhD
Affiliated Hospital of Hebei University
Principal Investigator - Minxiu Yao, MD，PhD
Qingdao Central Hospital
Principal Investigator - Tao Ning, MD，PhD
Baotou Central Hospital
Principal Investigator - Wei Zhang, MD，PhD
Qiqihar First Hospital
Principal Investigator - WeiHong Song, MD，PhD
First People's Hospital of Chenzhou
Principal Investigator - Xiaohong Lin, MD，PhD
ZhuZhou Central Hospital
Principal Investigator - Xiaohong Wu, MD，PhD
Zhejiang Province People's Hospital
Principal Investigator - XinLing Wang, Doctor
People's Hospital of Xinjiang Uygur Autonomous Region
Principal Investigator - Xueying Wang, MD，PhD
Jingzhou Central Hospital
Principal Investigator - YanJun Wang, MD，PhD
Second Hospital of Jilin University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Beijing University People'S Hospital
Beijing, Beijing Municipality, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Jun 2020
- Primary completion
- 15 Sept 2022
- Completion
- 26 May 2023
- Last update posted
- 28 Jul 2023
- Registered enrollment
- 620
- Registry id
- NCT04504396
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.